Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Change in Receivables (2016 - 2025)

Sangamo Therapeutics (SGMO) has disclosed Change in Receivables for 16 consecutive years, with -$152000.0 as the latest value for Q4 2025.

  • For Q4 2025, Change in Receivables rose 98.48% year-over-year to -$152000.0; the TTM value through Dec 2025 reached -$155000.0, up 60.96%, while the annual FY2025 figure was -$155000.0, 60.96% up from the prior year.
  • Change in Receivables hit -$152000.0 in Q4 2025 for Sangamo Therapeutics, down from $151000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $9.9 million in Q3 2024 and bottomed at -$10.0 million in Q4 2024.
  • Average Change in Receivables over 5 years is -$242650.0, with a median of -$156000.0 recorded in 2025.
  • On a YoY basis, Change in Receivables climbed as much as 732.33% in 2024 and fell as far as 4331.11% in 2024.
  • Sangamo Therapeutics' Change in Receivables stood at -$2.0 million in 2021, then surged by 56.81% to -$844000.0 in 2022, then soared by 73.34% to -$225000.0 in 2023, then plummeted by 4331.11% to -$10.0 million in 2024, then skyrocketed by 98.48% to -$152000.0 in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$152000.0, $151000.0, and $6000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.